Enovis Corporation Common Stock (ENOV)

Margins widened and guidance moved higher despite regional headwinds.

What happened? Shares of medical technology company Enovis Corporation (NYSE:ENOV) jumped 16.5% in the morning session after the company reported third-quart...

Medical technology company Enovis Corporation (NYSE:ENOV) met Wall Street’s revenue expectations in Q3 2026, with revenue up 1.8% year on year to $558.7 mill...

What happened? A number of stocks jumped in the afternoon session after election results confirmed that Democrats reclaimed majorities in the House and Senat...

Medical technology company Enovis Corporation (NYSE:ENOV) will be reporting earnings this Thursday before market open. Here’s what you need to know. Enovis m...

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ...

Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th...

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not on...

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember...

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th...

Rock-bottom prices don’t always mean rock-bottom businesses. The stocks we’re examining today have all touched their 52-week lows, creating a classic investo...

Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resou...

Shareholders of Enovis would probably like to forget the past six months even happened. The stock dropped 20.4% and now trades at $18.67. This may have inves...

Engert's $150,000 purchase represents a 14% increase to his direct holdings, signaling confidence despite stock's -37% one-year decline.

As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - specialty industry, including En...

Enovis (NYSE:ENOV) said it has entered a binding offer to acquire eCential Robotics, a developer of surgical robotics technology, in a move the orthopedic company said will expand its enabling-technology capabilities and accelerate its pathway into robotic surgery. Chief Executive Officer Damien Mc

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...

Enovis (NYSE:ENOV) reported second-quarter 2026 sales of $583 million, up 3% on a reported basis and 5% organically, as growth in its Reconstruction business offset a slower but still expanding Performance & Recovery segment. Management said the company’s results reflected improved commercial ex

What Happened? Shares of medical technology company Enovis Corporation (NYSE:ENOV) fell 12.8% in the afternoon session after the company reported second-quar...

Medical technology company Enovis Corporation (NYSE:ENOV) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 3.2% year on year to $582.8 mill...

Medical technology company Enovis Corporation (NYSE:ENOV) will be reporting earnings this Thursday morning. Here’s what to expect. Enovis beat analysts’ reve...

Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th...

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic...

What Happened? A number of stocks fell in the afternoon session after a key industry player warned that changes to some insurance plans could slow U.S. proce...